CHRND Antikörper (AA 22-245)
-
- Target Alle CHRND Antikörper anzeigen
- CHRND (Cholinergic Receptor, Nicotinic, delta (Muscle) (CHRND))
-
Bindungsspezifität
- AA 22-245
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CHRND Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Verwendungszweck
- CHRND Antibody
- Aufreinigung
- Purified antibody
- Immunogen
- Purified recombinant fragment of human CHRND (AA: 22-245) expressed in E. Coli.
- Klon
- 1H1F9
- Isotyp
- IgG1
-
-
- Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
- Target
- CHRND (Cholinergic Receptor, Nicotinic, delta (Muscle) (CHRND))
- Andere Bezeichnung
- CHRND (CHRND Produkte)
- Hintergrund
-
Description: The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene.
Aliases: ACHRD, CMS2A, CMS3A, CMS3B, CMS3C, FCCMS, SCCMS
- Molekulargewicht
- 58.8kDa
- Gen-ID
- 1144
- HGNC
- 1144
- UniProt
- Q07001
-